MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro

• Susan Fischer-Huchzermeyer ,

  Contributed equally to this work with: Susan Fischer-Huchzermeyer, Anna Dombrowski

  Roles Data curation, Formal analysis, Investigation, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Institute of Neuropathology, University Hospital Münster, Münster, Germany

  ⨯
• Anna Dombrowski ,

  Contributed equally to this work with: Susan Fischer-Huchzermeyer, Anna Dombrowski

  Roles Data curation, Formal analysis, Validation, Visualization

  Affiliation Clinics of Radiotherapy, HELIOS Clinic Berlin-Buch, Berlin, Germany

  ⨯
• Gordon Wilke,

  Roles Data curation, Formal analysis, Methodology, Writing – original draft

  Affiliation Department of Neuropathology, Charité-Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Verena Stahn,

  Roles Formal analysis, Writing – original draft

  Affiliation Institute of Neuropathology, University Hospital Münster, Münster, Germany

  ⨯
• Anna Streubel,

  Roles Data curation, Formal analysis, Methodology, Validation

  Affiliation Institute of Pathology, HELIOS Clinic Emil von Behring, Berlin, Germany

  ⨯
• Victor Felix Mautner,

  Roles Project administration, Writing – review & editing

  Affiliation Clinics and Polyclinics of Neurology, University Hospital Hamburg-Eppendorf, Hamburg, Germany

  ⨯
• Anja Harder

  Roles Conceptualization, Funding acquisition, Investigation, Project administration, Resources, Supervision, Validation, Writing – original draft, Writing – review & editing

  * E-mail: anja.harder@ukmuenster.de

  Affiliations Institute of Neuropathology, University Hospital Münster, Münster, Germany, Institute of Pathology, Medical University Brandenburg, Brandenburg, Germany

  http://orcid.org/0000-0002-3045-2222

  ⨯